Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
Fungal infections are prevalent in patients with immune diseases. Voriconazole, a triazole antifungal drug, inhibits the cytochromes CYP3A4 and CYP2C, and tofacitinib, a Janus kinase inhibitor for the treatment of rheumatoid arthritis, is metabolized by CYP3A4 and CYP2C19 in humans. Here, we investi...
Saved in:
Main Authors: | Ji-Sang Lee (Author), Hyo-Sung Kim (Author), Yong-Seob Jung (Author), Hyeon-Gyeom Choi (Author), So-Hee Kim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Hyperlipidemia on the Pharmacokinetics of Tofacitinib, a JAK 1/3 Inhibitor, in Rats
by: Jong Mun Won, et al.
Published: (2023) -
Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with <i>N</i>-Dimethylnitrosamine-Induced Liver Cirrhosis
by: Sung Hun Bae, et al.
Published: (2022) -
Dose-Dependent Pharmacokinetics of Tofacitinib in Rats: Influence of Hepatic and Intestinal First-Pass Metabolism
by: Ji Sang Lee, et al.
Published: (2019) -
Effects of naringenin on the pharmacokinetics of tofacitinib in rats
by: Bo Wang, et al.
Published: (2020) -
Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
by: Shen J, et al.
Published: (2020)